IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

HARRY E BURCK

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1629064738
CMS profile
28643
Location
MC MINNVILLE, TN

General Payments · PY2018–2024

$4,089.57

  • Reported across 255 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$879.65

51 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Internal Medicine TN All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $879.65 51

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $330.90 16
NOVARTIS PHARMACEUTICALS CORPORATION $150.39 12
Novo Nordisk AS $105.01 6
Lilly USA, LLC $99.96 5
Bayer HealthCare Pharmaceuticals Inc. $50.57 3
Exact Sciences Corporation $45.57 3
Otsuka America Pharmaceutical, Inc. $35.72 2
Amgen Inc. $28.45 2
Xeris Pharmaceuticals, Inc. $16.81 1
Lundbeck LLC $16.27 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $414.42 29
PY2019 $177.90 12
PY2020 $306.56 21
PY2021 $523.44 34
PY2022 $800.41 50
PY2023 $987.19 58
PY2024 $879.65 51

Payment records · PY2024 (51)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $13.42 03/26/2024 Food and Beverage Undisputed 01/23/2026 1117213520 CMS
Amgen Inc. $15.03 07/22/2024 Food and Beverage Undisputed 01/23/2026 1117213522 CMS
AstraZeneca Pharmaceuticals LP $22.97 01/26/2024 Food and Beverage Undisputed 01/23/2026 1104699435 CMS
AstraZeneca Pharmaceuticals LP $17.62 02/28/2024 Food and Beverage Undisputed 01/23/2026 1104427487 CMS
AstraZeneca Pharmaceuticals LP $21.33 03/20/2024 Food and Beverage Undisputed 01/23/2026 1104298432 CMS
AstraZeneca Pharmaceuticals LP $18.85 03/28/2024 Food and Beverage Undisputed 01/23/2026 1105891578 CMS
AstraZeneca Pharmaceuticals LP $13.32 04/03/2024 Food and Beverage Undisputed 01/23/2026 1104756482 CMS
AstraZeneca Pharmaceuticals LP $22.42 04/08/2024 Food and Beverage Undisputed 01/23/2026 1105634508 CMS
AstraZeneca Pharmaceuticals LP $19.95 04/29/2024 Food and Beverage Undisputed 01/23/2026 1105685175 CMS
AstraZeneca Pharmaceuticals LP $24.66 05/14/2024 Food and Beverage Undisputed 01/23/2026 1104361347 CMS
AstraZeneca Pharmaceuticals LP $18.06 05/29/2024 Food and Beverage Undisputed 01/23/2026 1104350304 CMS
AstraZeneca Pharmaceuticals LP $23.25 07/29/2024 Food and Beverage Undisputed 01/23/2026 1105745931 CMS
AstraZeneca Pharmaceuticals LP $19.49 08/06/2024 Food and Beverage Undisputed 01/23/2026 1104702939 CMS
AstraZeneca Pharmaceuticals LP $23.22 08/29/2024 Food and Beverage Undisputed 01/23/2026 1104320524 CMS
AstraZeneca Pharmaceuticals LP $16.83 09/04/2024 Food and Beverage Undisputed 01/23/2026 1105281058 CMS
AstraZeneca Pharmaceuticals LP $17.77 10/01/2024 Food and Beverage Undisputed 01/23/2026 1105655372 CMS
AstraZeneca Pharmaceuticals LP $30.29 10/09/2024 Food and Beverage Undisputed 01/23/2026 1104706503 CMS
AstraZeneca Pharmaceuticals LP $20.87 12/09/2024 Food and Beverage Undisputed 01/23/2026 1104419431 CMS
Bayer Healthcare Pharmaceuticals Inc. $15.41 04/01/2024 Food and Beverage Undisputed 01/23/2026 1086210569 CMS
Bayer Healthcare Pharmaceuticals Inc. $17.36 04/23/2024 Food and Beverage Undisputed 01/23/2026 1086219511 CMS
Bayer Healthcare Pharmaceuticals Inc. $17.80 07/02/2024 Food and Beverage Undisputed 01/23/2026 1086211895 CMS
Exact Sciences Corporation $14.77 02/21/2024 Food and Beverage Undisputed 01/23/2026 1114602804 CMS
Exact Sciences Corporation $15.27 06/05/2024 Food and Beverage Undisputed 01/23/2026 1114602808 CMS
Exact Sciences Corporation $15.53 09/12/2024 Food and Beverage Undisputed 01/23/2026 1114602812 CMS
Lilly USA, LLC $20.18 01/22/2024 Food and Beverage Undisputed 01/23/2026 1134996652 CMS
Lilly USA, LLC $21.23 03/18/2024 Food and Beverage Undisputed 01/23/2026 1134997030 CMS
Lilly USA, LLC $21.24 04/22/2024 Food and Beverage Undisputed 01/23/2026 1135021472 CMS
Lilly USA, LLC $23.74 05/20/2024 Food and Beverage Undisputed 01/23/2026 1134999110 CMS
Lilly USA, LLC $13.57 11/21/2024 Food and Beverage Undisputed 01/23/2026 1134996654 CMS
Lundbeck LLC $16.27 12/10/2024 Food and Beverage Undisputed 01/23/2026 1145901412 CMS
Novartis Pharmaceuticals Corporation $16.60 02/06/2024 Food and Beverage Undisputed 01/23/2026 1086726867 CMS
Novartis Pharmaceuticals Corporation $17.17 03/25/2024 Food and Beverage Undisputed 01/23/2026 1086726871 CMS
Novartis Pharmaceuticals Corporation $15.36 04/30/2024 Food and Beverage Undisputed 01/23/2026 1086726875 CMS
Novartis Pharmaceuticals Corporation $16.10 06/03/2024 Food and Beverage Undisputed 01/23/2026 1086726883 CMS
Novartis Pharmaceuticals Corporation $14.05 06/27/2024 Food and Beverage Undisputed 01/23/2026 1086726885 CMS
Novartis Pharmaceuticals Corporation $9.82 08/01/2024 Food and Beverage Undisputed 01/23/2026 1086726889 CMS
Novartis Pharmaceuticals Corporation $6.31 09/10/2024 Food and Beverage Undisputed 01/23/2026 1086726891 CMS
Novartis Pharmaceuticals Corporation $0.63 09/10/2024 Food and Beverage Undisputed 01/23/2026 1086726893 CMS
Novartis Pharmaceuticals Corporation $17.07 09/26/2024 Food and Beverage Undisputed 01/23/2026 1086726895 CMS
Novartis Pharmaceuticals Corporation $8.79 10/29/2024 Food and Beverage Undisputed 01/23/2026 1086726901 CMS
Novartis Pharmaceuticals Corporation $4.03 11/19/2024 Food and Beverage Undisputed 01/23/2026 1086726905 CMS
Novartis Pharmaceuticals Corporation $24.46 12/05/2024 Food and Beverage Undisputed 01/23/2026 1086726903 CMS
Novo Nordisk Inc $22.54 01/18/2024 Food and Beverage Undisputed 01/23/2026 1097563621 CMS
Novo Nordisk Inc $17.83 03/05/2024 Food and Beverage Undisputed 01/23/2026 1096938775 CMS
Novo Nordisk Inc $14.43 05/20/2024 Food and Beverage Undisputed 01/23/2026 1097021203 CMS
Novo Nordisk Inc $13.79 07/23/2024 Food and Beverage Undisputed 01/23/2026 1096912276 CMS
Novo Nordisk Inc $15.79 08/08/2024 Food and Beverage Undisputed 01/23/2026 1097499655 CMS
Novo Nordisk Inc $20.63 10/23/2024 Food and Beverage Undisputed 01/23/2026 1097539642 CMS
Otsuka America Pharmaceutical, Inc. $19.37 04/04/2024 Food and Beverage Undisputed 01/23/2026 1118869104 CMS
Otsuka America Pharmaceutical, Inc. $16.35 06/24/2024 Food and Beverage Undisputed 01/23/2026 1118869106 CMS
Xeris Pharmaceuticals, Inc. $16.81 11/19/2024 Food and Beverage Undisputed 01/23/2026 1144596202 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.